Vestcor Inc Novo Cure LTD Transaction History

Vestcor Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$63.98 - $85.37 $1,151 - $1,536	18 Added 0.81%	2,236 $164,000
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $2,107 - $2,776	31 Added 1.42%	2,218 $169,000
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $40,129 - $63,739	709 Added 47.97%	2,187 $152,000
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $74,104 - $104,128	-1,232 Reduced 45.46%	1,478 $122,000
Q4 2021 Feb 15, 2022	SELL	$75.08 - $121.99 $30,032 - $48,796	-400 Reduced 12.86%	2,710 $203,000
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $19,865 - $33,268	-171 Reduced 5.21%	3,110 $361,000
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $201,728 - $348,972	1,547 Added 89.22%	3,281 $728,000
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $99,184 - $129,026	1,734 New	1,734 $103,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

Stay updated on Vestcor Inc with notifications on news.